| |
|
|
| Name: |
Octagon Capital Advisors LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10065 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
65 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APLS |
Apellis Pharmaceuticals Inc |
1 |
- |
$42.56 |
$164,994,000 |
2,806,980 |
20.06% |
-3,032,000 |
0 |
2.452 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
2 |
- |
$64.97 |
$49,205,000 |
1,241,300 |
5.98% |
25,546,000 |
0 |
1.894 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
3 |
- |
$0.70 |
$41,420,000 |
1,380,667 |
5.04% |
35,658,000 |
826,667 |
9.316 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
4 |
- |
$0.00 |
$38,117,000 |
2,369,000 |
4.63% |
-8,979,000 |
0 |
2.936 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
5 |
- |
$32.63 |
$35,287,000 |
1,242,945 |
4.29% |
24,741,000 |
450,000 |
1.532 |
N/A |
|
|
AVBP |
Arrivent Biopharma, Inc. |
6 |
New |
$19.95 |
$34,717,000 |
1,943,836 |
4.22% |
34,717,000 |
1,943,836 |
5.804 |
N/A |
|
|
INSM |
Insmed Inc |
7 |
- |
$24.53 |
$30,928,000 |
1,140,000 |
3.76% |
-8,863,000 |
-144,000 |
0.752 |
Biotechnology |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
8 |
- |
$0.00 |
$23,279,000 |
2,060,100 |
2.83% |
6,881,000 |
0 |
2.357 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
9 |
New |
$0.44 |
$22,603,000 |
1,093,503 |
2.75% |
22,603,000 |
1,093,503 |
0.762 |
Biotechnology |
|
|
OCUL |
Ocular Therapeutix, Inc |
10 |
New |
$0.00 |
$22,068,000 |
2,425,000 |
2.68% |
22,068,000 |
2,425,000 |
2.2 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
11 |
- |
$35.81 |
$21,713,000 |
506,604 |
2.64% |
4,838,000 |
92,604 |
1.092 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
12 |
- |
$29.28 |
$21,335,000 |
690,000 |
2.59% |
-7,199,000 |
-16,800 |
0.397 |
N/A |
|
|
MNMD |
Mind Medicine |
13 |
New |
$8.35 |
$20,238,000 |
2,153,000 |
2.46% |
20,238,000 |
2,153,000 |
6.06 |
N/A |
|
|
ISR |
IsoRay, Inc. |
14 |
New |
$1.59 |
$17,515,000 |
14,718,422 |
2.13% |
17,515,000 |
14,718,422 |
26.753 |
Medical Instruments &... |
|
|
CRBP |
Corbus Pharmaceuticals Hold... |
15 |
New |
$45.20 |
$15,892,000 |
405,000 |
1.93% |
15,892,000 |
405,000 |
0.323 |
N/A |
|
|
PRAX |
Praxis Precision Medicines,... |
16 |
New |
$0.00 |
$15,865,000 |
260,000 |
1.93% |
15,865,000 |
260,000 |
0.496 |
N/A |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
17 |
New |
$0.00 |
$14,926,000 |
2,854,000 |
1.81% |
14,926,000 |
2,854,000 |
4.46 |
N/A |
|
|
JSPR |
Jasper Therapeutics Ord Shs |
18 |
- |
$15.12 |
$14,704,000 |
500,811 |
1.79% |
11,179,000 |
-3,967,303 |
0.493 |
N/A |
|
|
ANNX |
Annexon, Inc. |
19 |
- |
$0.00 |
$14,699,000 |
2,050,000 |
1.79% |
5,392,000 |
0 |
2.381 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
20 |
- |
$60.14 |
$13,601,000 |
194,000 |
1.65% |
3,916,000 |
78,000 |
0.158 |
Biotechnology |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
21 |
- |
$0.00 |
$11,937,000 |
403,685 |
1.45% |
2,802,000 |
0 |
1.459 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
22 |
- |
$12.88 |
$10,856,000 |
620,000 |
1.32% |
-2,648,000 |
0 |
0.989 |
N/A |
|
|
GOSS |
Gossamer Bio Inc |
23 |
- |
$0.67 |
$10,842,000 |
9,187,883 |
1.32% |
2,458,000 |
0 |
4.076 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
24 |
New |
$0.00 |
$9,649,000 |
408,000 |
1.17% |
9,649,000 |
408,000 |
0.5 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
25 |
- |
$0.28 |
$9,000,000 |
3,000,000 |
1.09% |
1,920,000 |
0 |
6.272 |
N/A |
|
|
IMVT |
Immunovant Inc |
26 |
- |
$0.00 |
$8,830,000 |
273,289 |
1.07% |
-2,684,000 |
0 |
0.314 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
27 |
- |
$0.00 |
$8,696,000 |
3,030,000 |
1.06% |
8,696,000 |
3,030,000 |
1.621 |
N/A |
|
|
AKRO |
Akero Therapeutics, Inc. |
28 |
New |
$0.00 |
$8,588,000 |
340,000 |
1.04% |
8,588,000 |
340,000 |
0.555 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
29 |
New |
$4.74 |
$8,256,000 |
1,501,114 |
1% |
8,256,000 |
1,501,114 |
2.985 |
N/A |
|
|
CYBN |
Cybin Inc |
30 |
New |
$0.35 |
$7,693,000 |
18,604,650 |
0.94% |
7,693,000 |
18,604,650 |
11.731 |
N/A |
|
|
ARWR |
Arrowhead Pharmaceuticals Inc |
31 |
New |
$25.02 |
$7,150,000 |
250,000 |
0.87% |
7,150,000 |
250,000 |
0.244 |
Business Services |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
32 |
New |
$0.00 |
$7,101,000 |
550,000 |
0.86% |
7,101,000 |
550,000 |
1.346 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
33 |
New |
$0.00 |
$6,804,000 |
315,000 |
0.83% |
6,804,000 |
315,000 |
1.057 |
N/A |
|
|
PEPG |
Pepgen Inc. |
34 |
New |
$13.89 |
$5,529,000 |
376,117 |
0.67% |
5,529,000 |
376,117 |
1.592 |
N/A |
|
|
VINC |
Vincerx Pharma, Inc |
35 |
New |
$0.72 |
$5,060,000 |
1,000,000 |
0.62% |
5,060,000 |
1,000,000 |
4.757 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
36 |
- |
$10.42 |
$5,005,000 |
1,374,870 |
0.61% |
3,495,000 |
374,870 |
0.635 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
37 |
- |
$0.00 |
$4,832,000 |
455,000 |
0.59% |
4,375,000 |
405,000 |
0.795 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
38 |
New |
$2.62 |
$4,480,000 |
1,000,000 |
0.54% |
4,480,000 |
1,000,000 |
0.829 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
39 |
New |
$6.12 |
$4,100,000 |
625,000 |
0.5% |
4,100,000 |
625,000 |
0.963 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
40 |
New |
$3.70 |
$3,823,000 |
520,800 |
0.46% |
3,823,000 |
520,800 |
0.439 |
Biotechnology |
|
|
RPHM |
Reneo Pharmaceuticals, Inc. |
41 |
- |
$1.89 |
$3,735,000 |
2,250,000 |
0.45% |
135,000 |
0 |
6.655 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
42 |
- |
$23.95 |
$3,716,000 |
165,000 |
0.45% |
1,146,000 |
45,000 |
0.519 |
N/A |
|
|
SANA |
Sana Biotechnology, Inc. |
43 |
New |
$0.00 |
$3,608,000 |
360,800 |
0.44% |
3,608,000 |
360,800 |
0.192 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
44 |
- |
$2.17 |
$3,585,000 |
1,103,000 |
0.44% |
-10,032,000 |
438,425 |
3.709 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
45 |
New |
$0.00 |
$3,218,000 |
720,000 |
0.39% |
3,218,000 |
720,000 |
0.513 |
N/A |
|
|
ALVR |
Allovir Inc |
46 |
New |
$0.80 |
$3,171,000 |
4,200,000 |
0.39% |
3,171,000 |
4,200,000 |
6.812 |
N/A |
|
|
VERU |
Veru Inc |
47 |
- |
$1.39 |
$2,660,000 |
3,800,000 |
0.32% |
-76,000 |
0 |
5.439 |
Personal Products |
|
|
RAPT |
Rapt Therapeutics, Inc. |
48 |
- |
$4.59 |
$2,622,000 |
292,000 |
0.32% |
-4,634,000 |
0 |
0.809 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
49 |
New |
$0.00 |
$2,594,000 |
240,000 |
0.32% |
2,594,000 |
240,000 |
0.493 |
N/A |
|
|
HLXB |
Helix Acquisition Corp. Ii |
50 |
New |
$10.25 |
$2,588,000 |
250,000 |
0.31% |
2,588,000 |
250,000 |
1.359 |
N/A |
|
|
PSTX |
Poseida Therapeutics, Inc. |
51 |
New |
$2.97 |
$2,348,000 |
736,000 |
0.29% |
2,348,000 |
736,000 |
1.191 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
52 |
New |
$0.00 |
$2,257,000 |
540,000 |
0.27% |
2,257,000 |
540,000 |
0.985 |
N/A |
|
|
ACET |
Adicet Bio, Inc |
53 |
New |
$1.61 |
$1,804,000 |
767,799 |
0.22% |
1,804,000 |
767,799 |
1.792 |
N/A |
|
|
LIFE |
aTyr Pharma Inc |
54 |
New |
$0.37 |
$1,365,000 |
700,000 |
0.17% |
1,365,000 |
700,000 |
1.195 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
55 |
New |
$3.87 |
$1,123,000 |
176,000 |
0.14% |
1,123,000 |
176,000 |
0.102 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
56 |
New |
$0.00 |
$887,000 |
52,000 |
0.11% |
887,000 |
52,000 |
0.101 |
N/A |
|
|
RCUS |
Arcus Biosciences Inc |
57 |
Closed |
$17.24 |
$0 |
0 |
0% |
-35,679,000 |
-1,868,000 |
0 |
N/A |
|
|
ROIV |
Roivant Sciences Ltd. |
61 |
Closed |
$11.23 |
$0 |
0 |
0% |
-28,008,000 |
-2,494,000 |
0 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
64 |
Closed |
$0.00 |
$0 |
0 |
0% |
-738,000 |
-25,000 |
0 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
60 |
Closed |
$32.48 |
$0 |
0 |
0% |
-63,154,000 |
-2,673,750 |
0 |
N/A |
|
|
INZY |
Inozyme Pharma, Inc. |
63 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,704,000 |
-400,000 |
0 |
N/A |
|
|
GRCL |
Gracell Biotechnologies Adr... |
62 |
Closed |
$0.00 |
$0 |
0 |
0% |
-5,990,000 |
-596,611 |
0 |
N/A |
|
|
ACRS |
Aclaris Therapeutics, Inc. |
59 |
Closed |
$1.18 |
$0 |
0 |
0% |
-105,000 |
-100,000 |
0 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
65 |
Closed |
$37.67 |
$0 |
0 |
0% |
-28,060,000 |
-707,526 |
0 |
Diagnostic Substances |
|
|
XLO |
Xilio Therapeutics, Inc. |
58 |
Closed |
$0.00 |
$0 |
0 |
0% |
-982,000 |
-1,785,000 |
0 |
N/A |
|
